Industry News

ENDRA Life Sciences’ NASH Test Device, TAEUS, At Commercialization Inflection Point (NASDAQ:NDRA)

ENDRA Life Sciences Inc. (NASDAQ:NDRA) recently announced it is moving forward with the commercialization of its Thermo Acoustic Enhanced UltraSound (TAEUS) device in Europe. The TAEUS device is essentially a point of care (POC) or field diagnostic hybrid of an ultrasound and MRI that can monitor the progression of one of the largest unmet medical needs worldwide.

Surgeons, device makers grow more confident in elective care comeback

“Medtech companies’ calls with investors following the first quarter offered some stark figures on the steep drop-off in elective procedures in light of COVID-19.
BD said its surgery revenues were down as much as 70% in April. Stryker, which estimated half of its business was vulnerable to deferrable procedures, projected a nearly 40% drop in April sales. At Boston Scientific and Smith & Nephew, that revenue cut was closer to 50%. Intuitive Surgical, one of the earliest major medtechs to report earnings, said da Vinci robot use fell 65% in late March.”